Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
2-4-1|Rn-BN25-0d-WL 0,7/84|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-1-1|1|7314|Other deterministic changes|Lower respiratory system|n/a|
2-4-1|Rn-BN25-0d-WL 0,7/84|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-1-2|1|350|Other deterministic changes|Lower respiratory system|n/a|
2-4-1|Rn-BN25-0d-WL 0,7/84|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-1-3|1|350|Other deterministic changes|Lower respiratory system|n/a|
2-4-1|Rn-BN25-0d-WL 0,7/84|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-1-4|1|350|Other deterministic changes|Lower respiratory system|n/a|
2-4-1|Rn-BN25-0d-WL 0,7/84|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-1-5|1|350|Other deterministic changes|Lower respiratory system|n/a|
2-4-1|Rn-BN25-0d-WL 0,7/84|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-1-6|1|350|Other deterministic changes|Lower respiratory system|n/a|
2-4-1|Rn-BN25-0d-WL 0,7/84|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-1-7|1|350|Other deterministic changes|Lower respiratory system|n/a|
2-4-1|Rn-BN25-0d-WL 0,7/84|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-1-8|1|377|Other deterministic changes|Lower respiratory system|n/a|
2-4-1|Rn-BN25-0d-WL 0,7/84|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-1-9|1|377|Other deterministic changes|Lower respiratory system|n/a|
2-4-1|Rn-BN25-0d-WL 0,7/84|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-1-10|1|377|Other deterministic changes|Lower respiratory system|n/a|
2-4-1|Rn-BN25-0d-WL 0,7/84|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-1-11|1|377|Other deterministic changes|Lower respiratory system|n/a|
2-4-1|Rn-BN25-0d-WL 0,7/84|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-1-12|1|377|Other deterministic changes|Lower respiratory system|n/a|
2-4-1|Rn-BN25-0d-WL 0,7/84|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-1-13|1|377|Other deterministic changes|Lower respiratory system|n/a|
2-4-1|Rn-BN25-0d-WL 0,7/84|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-1-14|1|377|Other deterministic changes|Lower respiratory system|n/a|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-1|2|402|Other deterministic changes|Lower respiratory system|n/a|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-2|2|406|Other deterministic changes|Lower respiratory system|n/a|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-3|2|414|Other deterministic changes|Lower respiratory system|n/a|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-4|2|428|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-5|2|491|Other deterministic changes|Lower respiratory system|n/a|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-6|2|491|Other deterministic changes|Lower respiratory system|n/a|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-7|2|527|Other deterministic changes|Lower respiratory system|n/a|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-8|2|563|Other deterministic changes|Lower respiratory system|n/a|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-9|2|596|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-10|2|619|Other deterministic changes|Lower respiratory system|n/a|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-11|2|623|Other deterministic changes|Lower respiratory system|n/a|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-12|2|625|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-13|2|630|Other deterministic changes|Lower respiratory system|n/a|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-14|2|666|Other deterministic changes|Lower respiratory system|n/a|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-15|2|681|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-16|2|682|Other deterministic changes|Lower respiratory system|n/a|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-17|2|682|Other deterministic changes|Lower respiratory system|n/a|
2-4-2|Rn-BN12*25+500d-WL 0,20 1/76|1|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-2-18|2|684|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-1|3|243|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-2|3|257|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-3|3|257|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-4|3|266|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-5|3|269|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-6|3|285|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-7|3|286|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-8|3|294|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-9|3|294|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-10|3|294|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-11|3|294|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-12|3|294|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-13|3|294|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-14|3|294|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-15|3|294|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-16|3|294|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-17|3|294|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-18|3|294|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-19|3|294|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-20|3|294|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-21|3|294|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-22|3|294|Other deterministic changes|Lower respiratory system|n/a|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-23|3|294|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-3|Rn-BN16*25+210d-WL 0,2/82|1|287|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|16 IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-3-24|3|294|Other deterministic changes|Lower respiratory system|n/a|
2-4-4|Rn-BN8*25+130d-WL 0,1/77|1|207|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-4-1|4|31|Other deterministic changes|Lower respiratory system|n/a|
2-4-4|Rn-BN8*25+130d-WL 0,1/77|1|207|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-4-2|4|187|Other deterministic changes|Lower respiratory system|n/a|
2-4-4|Rn-BN8*25+130d-WL 0,1/77|1|207|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-4-3|4|209|Other deterministic changes|Lower respiratory system|n/a|
2-4-4|Rn-BN8*25+130d-WL 0,1/77|1|207|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-4-4|4|209|Other deterministic changes|Lower respiratory system|n/a|
2-4-4|Rn-BN8*25+130d-WL 0,1/77|1|207|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-4-5|4|209|Other deterministic changes|Lower respiratory system|n/a|
2-4-4|Rn-BN8*25+130d-WL 0,1/77|1|207|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-4-6|4|209|Other deterministic changes|Lower respiratory system|n/a|
2-4-4|Rn-BN8*25+130d-WL 0,1/77|1|207|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-4-7|4|209|Other deterministic changes|Lower respiratory system|n/a|
2-4-4|Rn-BN8*25+130d-WL 0,1/77|1|207|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-4-8|4|209|Neoplasia benign|Lower respiratory system|n/a|
2-4-4|Rn-BN8*25+130d-WL 0,1/77|1|207|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-4-9|4|209|Other deterministic changes|Lower respiratory system|+code 11 ???|
2-4-4|Rn-BN8*25+130d-WL 0,1/77|1|207|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-4-10|4|209|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-4|Rn-BN8*25+130d-WL 0,1/77|1|207|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-4-11|4|209|Other deterministic changes|Lower respiratory system|n/a|
2-4-4|Rn-BN8*25+130d-WL 0,1/77|1|207|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-4-12|4|209|Other deterministic changes|Lower respiratory system|n/a|
2-4-5|Rn-BN25+144d-WL 0,26-10 1/77|1|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-5-1|5|252|Other deterministic changes|Lower respiratory system|n/a|
2-4-5|Rn-BN25+144d-WL 0,26-10 1/77|1|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-5-2|5|529|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-5|Rn-BN25+144d-WL 0,26-10 1/77|1|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-5-3|5|586|Other deterministic changes|Lower respiratory system|n/a|
2-4-5|Rn-BN25+144d-WL 0,26-10 1/77|1|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-5-4|5|586|Other deterministic changes|Lower respiratory system|n/a|
2-4-5|Rn-BN25+144d-WL 0,26-10 1/77|1|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-5-5|5|657|Other deterministic changes|Lower respiratory system|n/a|
2-4-5|Rn-BN25+144d-WL 0,26-10 1/77|1|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-5-6|5|671|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-5|Rn-BN25+144d-WL 0,26-10 1/77|1|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-5-7|5|699|Other deterministic changes|Lower respiratory system|n/a|
2-4-5|Rn-BN25+144d-WL 0,26-10 1/77|1|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-5-8|5|728|Neoplasia systemic|Haematolymphatic system|n/a|
2-4-5|Rn-BN25+144d-WL 0,26-10 1/77|1|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-5-9|5|754|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-5|Rn-BN25+144d-WL 0,26-10 1/77|1|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-5-10|5|758|Other deterministic changes|Lower respiratory system|n/a|
2-4-5|Rn-BN25+144d-WL 0,26-10 1/77|1|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-5-11|5|781|Other deterministic changes|Lower respiratory system|n/a|
2-4-5|Rn-BN25+144d-WL 0,26-10 1/77|1|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-5-12|5|813|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-5|Rn-BN25+144d-WL 0,26-10 1/77|1|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-5-13|5|830|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-5|Rn-BN25+144d-WL 0,26-10 1/77|1|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-5-14|5|841|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-1|6|28|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-2|6|28|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-3|6|37|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-4|6|47|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-5|6|47|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-6|6|51|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-7|6|254|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-8|6|254|Neoplasia malignant|Reproductive system,MA: 0000404 - prostate gland|benign,MPATH: 268 - adenocarcinoma|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-9|6|258|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-10|6|265|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-11|6|274|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-12|6|285|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-13|6|285|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-14|6|286|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-15|6|289|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-16|6|291|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-17|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-18|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-19|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-20|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-21|6|310|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-22|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-23|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-24|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-25|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-26|6|310|Hyperplastic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-27|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-28|6|310|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-29|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-30|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-31|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-32|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-33|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-34|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-35|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-36|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-6|Rn-BN12*25+150d-WL 0,1/77|1|305|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject.|37 (37 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-6-37|6|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-7|Rn-BN25+170d-WL 0,26-4 1/77|1|244|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-7-1|7|396|Other deterministic changes|Lower respiratory system|n/a|
2-4-7|Rn-BN25+170d-WL 0,26-4 1/77|1|244|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-7-2|7|536|Other deterministic changes|Lower respiratory system|n/a|
2-4-7|Rn-BN25+170d-WL 0,26-4 1/77|1|244|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-7-3|7|630|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-7|Rn-BN25+170d-WL 0,26-4 1/77|1|244|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-7-4|7|657|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-4-7|Rn-BN25+170d-WL 0,26-4 1/77|1|244|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-7-5|7|684|Neoplasia malignant|Lymphatic vessels among cardiovascular system|benign|
2-4-7|Rn-BN25+170d-WL 0,26-4 1/77|1|244|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-7-6|7|693|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-7|Rn-BN25+170d-WL 0,26-4 1/77|1|244|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-7-7|7|704|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-7|Rn-BN25+170d-WL 0,26-4 1/77|1|244|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-7-8|7|725|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-4-7|Rn-BN25+170d-WL 0,26-4 1/77|1|244|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-7-9|7|764|Other deterministic changes|Lower respiratory system|n/a|
2-4-7|Rn-BN25+170d-WL 0,26-4 1/77|1|244|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-7-10|7|774|Other deterministic changes|Lower respiratory system|n/a|
2-4-7|Rn-BN25+170d-WL 0,26-4 1/77|1|244|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-7-11|7|816|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-7|Rn-BN25+170d-WL 0,26-4 1/77|1|244|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-7-12|7|837|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-7|Rn-BN25+170d-WL 0,26-4 1/77|1|244|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-7-13|7|839|Other deterministic changes|Lower respiratory system|n/a|
2-4-7|Rn-BN25+170d-WL 0,26-4 1/77|1|244|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-7-14|7|846|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-1|8|248|Other deterministic changes|Lower respiratory system|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-2|8|252|Other deterministic changes|Lower respiratory system|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-3|8|252|Other deterministic changes|Lower respiratory system|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-4|8|557|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-5|8|608|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-6|8|645|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-7|8|660|Other deterministic changes|Lower respiratory system|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-8|8|719|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-9|8|790|Other deterministic changes|Lower respiratory system|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-10|8|790|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-11|8|813|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-12|8|813|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-13|8|822|Other deterministic changes|Lower respiratory system|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-14|8|829|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-15|8|831|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-16|8|841|Other deterministic changes|Lower respiratory system|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-1|8|248|Other deterministic changes|Lower respiratory system|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-2|8|252|Other deterministic changes|Lower respiratory system|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-3|8|252|Other deterministic changes|Lower respiratory system|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-4|8|557|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-5|8|608|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-6|8|645|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-7|8|660|Other deterministic changes|Lower respiratory system|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-8|8|719|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-9|8|790|Other deterministic changes|Lower respiratory system|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-10|8|790|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-11|8|813|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-12|8|813|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-13|8|822|Other deterministic changes|Lower respiratory system|n/a|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-14|8|829|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-15|8|831|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-4-8|Rn-BN3+144d-WL 40,26-9 1/77|2|221|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-8-16|8|841|Other deterministic changes|Lower respiratory system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-1|9|247|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-2|9|410|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-3|9|417|Neoplasia malignant|Lymphatic vessels among cardiovascular system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-4|9|652|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|benign,MPATH: 551 - sarcoma|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-5|9|671|Other deterministic changes|Lower respiratory system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-6|9|676|Other deterministic changes|Whole body|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-7|9|711|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-8|9|711|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-9|9|717|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-10|9|733|Neoplasia malignant|Lower respiratory system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-11|9|739|Other deterministic changes|Lower respiratory system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-12|9|747|Other deterministic changes|Lower respiratory system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-13|9|784|Other deterministic changes|Lower respiratory system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-14|9|825|Other deterministic changes|Lower respiratory system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-15|9|838|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|1|77|Rn-222 gas|40|working level months|Inhalation|inhaled over 1 m at 120 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-16|9|841|Neoplasia malignant|Lower respiratory system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-1|9|247|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-2|9|410|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-3|9|417|Neoplasia malignant|Lymphatic vessels among cardiovascular system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-4|9|652|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|benign,MPATH: 551 - sarcoma|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-5|9|671|Other deterministic changes|Lower respiratory system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-6|9|676|Other deterministic changes|Whole body|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-7|9|711|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-8|9|711|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-9|9|717|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-10|9|733|Neoplasia malignant|Lower respiratory system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-11|9|739|Other deterministic changes|Lower respiratory system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-12|9|747|Other deterministic changes|Lower respiratory system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-13|9|784|Other deterministic changes|Lower respiratory system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-14|9|825|Other deterministic changes|Lower respiratory system|n/a|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-15|9|838|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-9|Rn-BN25+144d-WL 40,26-1 1/77|2|221|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-9-16|9|841|Neoplasia malignant|Lower respiratory system|n/a|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-1|10|365|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-2|10|441|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-3|10|451|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-4|10|485|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-5|10|493|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-6|10|493|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-7|10|498|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-8|10|502|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-9|10|534|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-10|10|537|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-11|10|554|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-12|10|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-13|10|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-14|10|634|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-15|10|648|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-10|Rn,???|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-16|10|648|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-1|10|365|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-2|10|441|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-3|10|451|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-4|10|485|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-5|10|493|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-6|10|493|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-7|10|498|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-8|10|502|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-9|10|534|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-10|10|537|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-11|10|554|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-12|10|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-13|10|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-14|10|634|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-15|10|648|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-10|Rn,???|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|repeated injection ?|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-10-16|10|648|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-1|11|381|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-2|11|370|Hyperplastic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-3|11|370|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-4|11|370|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-5|11|370|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-6|11|370|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|benign,MPATH: 549 - carcinoma|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-7|11|370|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-8|11|370|Neoplasia benign|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-9|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-10|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-11|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-12|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-13|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-14|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-15|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|1|77|Rn-222 gas|50|working level months|Inhalation|inhaled over 1 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-16|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-1|11|381|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-2|11|370|Hyperplastic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-3|11|370|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-4|11|370|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-5|11|370|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-6|11|370|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|benign,MPATH: 549 - carcinoma|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-7|11|370|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-8|11|370|Neoplasia benign|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-9|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-10|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-11|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-12|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-13|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-14|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-15|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-11|Rn-BN25+265d-WL 50,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-11-16|11|446|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-1|12|377|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-2|12|400|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-3|12|400|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-4|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-5|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-6|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-7|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-8|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-9|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-10|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-11|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-12|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-13|12|476|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-14|12|476|Neoplasia benign|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-15|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|1|77|Rn-222 gas|100|working level months|Inhalation|inhaled over 2 m at 150 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-16|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-1|12|377|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-2|12|400|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-3|12|400|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-4|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-5|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-6|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-7|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-8|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-9|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-10|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-11|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-12|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-13|12|476|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-14|12|476|Neoplasia benign|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-15|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-12|Rn-BN25+265d-WL 100,12/82|2|342|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|10 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-12-16|12|476|Other deterministic changes|Lower respiratory system|n/a|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-1|13|519|Other deterministic changes|Lower respiratory system|n/a|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-2|13|566|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-3|13|566|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-4|13|583|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-5|13|618|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-6|13|637|Neoplasia benign|Lower respiratory system|n/a|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-7|13|672|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-8|13|701|Hyperplastic changes|Lower respiratory system|n/a|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-9|13|713|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-10|13|728|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-11|13|740|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-12|13|746|Neoplasia malignant|Lower respiratory system|n/a|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-13|13|766|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-14|13|770|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-15|13|786|Neoplasia malignant|Liver among hepato-pancreatic system diseases|benign|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-16|13|820|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-1|13|519|Other deterministic changes|Lower respiratory system|n/a|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-2|13|566|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-3|13|566|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-4|13|583|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-5|13|618|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-6|13|637|Neoplasia benign|Lower respiratory system|n/a|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-7|13|672|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-8|13|701|Hyperplastic changes|Lower respiratory system|n/a|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-9|13|713|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-10|13|728|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-11|13|740|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-12|13|746|Neoplasia malignant|Lower respiratory system|n/a|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-13|13|766|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-14|13|770|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-15|13|786|Neoplasia malignant|Liver among hepato-pancreatic system diseases|benign|
2-4-13|Rn-BN9+137d-WL 200,26-8 1/77|2|214|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-13-16|13|820|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-1|14|243|Other deterministic changes|Lower respiratory system|n/a|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-2|14|569|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-3|14|585|Neoplasia benign|Lower respiratory system|n/a|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-4|14|588|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-5|14|666|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-6|14|680|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-7|14|681|Hyperplastic changes|Lower respiratory system|n/a|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-8|14|699|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-9|14|710|Neoplasia malignant|Lower respiratory system|n/a|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-10|14|724|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-11|14|746|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-12|14|766|Neoplasia benign|Lower respiratory system|n/a|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-13|14|766|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-14|14|821|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-15|14|827|Hyperplastic changes|Lower respiratory system|n/a|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|1|77|Rn-222 gas|200|working level months|Inhalation|inhaled over 0.5 m at 800 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-16|14|827|Hyperplastic changes|Lower respiratory system|n/a|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-1|14|243|Other deterministic changes|Lower respiratory system|n/a|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-2|14|569|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-3|14|585|Neoplasia benign|Lower respiratory system|n/a|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-4|14|588|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-5|14|666|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-6|14|680|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-7|14|681|Hyperplastic changes|Lower respiratory system|n/a|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-8|14|699|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-9|14|710|Neoplasia malignant|Lower respiratory system|n/a|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-10|14|724|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-11|14|746|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-12|14|766|Neoplasia benign|Lower respiratory system|n/a|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-13|14|766|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-14|14|821|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-15|14|827|Hyperplastic changes|Lower respiratory system|n/a|
2-4-14|Rn-BN25+137d-WL 200,26-2 1/77|2|214|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 1 w interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-14-16|14|827|Hyperplastic changes|Lower respiratory system|n/a|
2-4-15|Rn-BN25+112d-WL 225,42-1a 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-15-1|15|278|Other deterministic changes|Lower respiratory system|n/a|
2-4-15|Rn-BN25+112d-WL 225,42-1a 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-15-2|15|287|Other deterministic changes|Lower respiratory system|n/a|
2-4-15|Rn-BN25+112d-WL 225,42-1a 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-15-3|15|287|Other deterministic changes|Lower respiratory system|n/a|
2-4-15|Rn-BN25+112d-WL 225,42-1a 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-15-4|15|287|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-15|Rn-BN25+112d-WL 225,42-1a 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|7 IM inject. 15 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-15-1|15|278|Other deterministic changes|Lower respiratory system|n/a|
2-4-15|Rn-BN25+112d-WL 225,42-1a 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|7 IM inject. 15 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-15-2|15|287|Other deterministic changes|Lower respiratory system|n/a|
2-4-15|Rn-BN25+112d-WL 225,42-1a 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|7 IM inject. 15 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-15-3|15|287|Other deterministic changes|Lower respiratory system|n/a|
2-4-15|Rn-BN25+112d-WL 225,42-1a 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|7 IM inject. 15 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-15-4|15|287|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-1|16|414|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-2|16|414|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-3|16|414|Other deterministic changes|Lower respiratory system|n/a|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-4|16|414|Hyperplastic changes|Lower respiratory system|n/a|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-5|16|414|Hyperplastic changes|Lower respiratory system|n/a|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-6|16|414|Other deterministic changes|Lower respiratory system|n/a|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-7|16|414|Neoplasia malignant|Lower respiratory system|n/a|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-8|16|414|Hyperplastic changes|Lower respiratory system|n/a|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-1|16|414|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-2|16|414|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-3|16|414|Other deterministic changes|Lower respiratory system|n/a|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-4|16|414|Hyperplastic changes|Lower respiratory system|n/a|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-5|16|414|Hyperplastic changes|Lower respiratory system|n/a|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-6|16|414|Other deterministic changes|Lower respiratory system|n/a|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-7|16|414|Neoplasia malignant|Lower respiratory system|n/a|
2-4-16|Rn-BN25+232d-WL 225,42-1c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|8 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-16-8|16|414|Hyperplastic changes|Lower respiratory system|n/a|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-1|17|447|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-2|17|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-3|17|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-4|17|472|Other deterministic changes|Lower respiratory system|n/a|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-5|17|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-6|17|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-7|17|472|Hyperplastic changes|Lower respiratory system|n/a|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|1|77|Rn-222 gas|225|working level months|Inhalation|inhaled over 0.07 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-8|17|472|Other deterministic changes|Lower respiratory system|n/a|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-1|17|447|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-2|17|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-3|17|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-4|17|472|Other deterministic changes|Lower respiratory system|n/a|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-5|17|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-6|17|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-7|17|472|Hyperplastic changes|Lower respiratory system|n/a|
2-4-17|Rn-BN25+232d-WL 225,42-1b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-17-8|17|472|Other deterministic changes|Lower respiratory system|n/a|
2-4-18|Rn-BN25+112d-WL 450,42-2a 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-18-1|18|264|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-18|Rn-BN25+112d-WL 450,42-2a 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-18-2|18|288|Other deterministic changes|Lower respiratory system|n/a|
2-4-18|Rn-BN25+112d-WL 450,42-2a 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-18-3|18|288|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-18|Rn-BN25+112d-WL 450,42-2a 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-18-4|18|288|Other deterministic changes|Lower respiratory system|n/a|
2-4-18|Rn-BN25+112d-WL 450,42-2a 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-18-1|18|264|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-18|Rn-BN25+112d-WL 450,42-2a 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-18-2|18|288|Other deterministic changes|Lower respiratory system|n/a|
2-4-18|Rn-BN25+112d-WL 450,42-2a 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-18-3|18|288|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-18|Rn-BN25+112d-WL 450,42-2a 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-18-4|18|288|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-1|19|393|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-2|19|393|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-3|19|393|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-4|19|393|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-5|19|407|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-6|19|407|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-7|19|407|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-8|19|407|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-1|19|393|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-2|19|393|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-3|19|393|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-4|19|393|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-5|19|407|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-6|19|407|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-7|19|407|Other deterministic changes|Lower respiratory system|n/a|
2-4-19|Rn-BN25+232d-WL 450,42-2c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-19-8|19|407|Other deterministic changes|Lower respiratory system|n/a|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-1|20|391|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-2|20|393|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-3|20|393|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-4|20|393|Other deterministic changes|Lower respiratory system|n/a|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-5|20|407|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-6|20|407|Neoplasia benign|Lower respiratory system|n/a|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-7|20|407|Neoplasia malignant|Lower respiratory system|n/a|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|1|77|Rn-222 gas|450|working level months|Inhalation|inhaled over 0.33 m at 1350 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-8|20|407|Other deterministic changes|Lower respiratory system|n/a|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-1|20|391|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-2|20|393|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-3|20|393|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-4|20|393|Other deterministic changes|Lower respiratory system|n/a|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-5|20|407|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-6|20|407|Neoplasia benign|Lower respiratory system|n/a|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-7|20|407|Neoplasia malignant|Lower respiratory system|n/a|
2-4-20|Rn-BN25*-232d-WL 450,42-2b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-20-8|20|407|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-1|21|17|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-2|21|59|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-3|21|75|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-4|21|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-5|21|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-6|21|331|Hyperplastic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-7|21|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-8|21|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-9|21|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-10|21|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-1|21|17|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-2|21|59|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-3|21|75|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-4|21|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-5|21|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-6|21|331|Hyperplastic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-7|21|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-8|21|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-9|21|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-21|Rn-BN25+3d-WL 500,43-11 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-21-10|21|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-1|22|272|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-2|22|273|Other deterministic changes|Lower respiratory system|n/a|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-3|22|273|Other deterministic changes|Lower respiratory system|n/a|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-4|22|341|Other deterministic changes|Lower respiratory system|n/a|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-5|22|455|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-6|22|483|Other deterministic changes|Lower respiratory system|n/a|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-7|22|538|Other deterministic changes|Lower respiratory system|n/a|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-8|22|552|Hyperplastic changes|Lower respiratory system|n/a|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-9|22|552|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-10|22|552|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|2|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-1|22|272|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|2|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-2|22|273|Other deterministic changes|Lower respiratory system|n/a|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|2|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-3|22|273|Other deterministic changes|Lower respiratory system|n/a|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|2|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-4|22|341|Other deterministic changes|Lower respiratory system|n/a|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|2|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-5|22|455|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|2|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-6|22|483|Other deterministic changes|Lower respiratory system|n/a|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|2|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-7|22|538|Other deterministic changes|Lower respiratory system|n/a|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|2|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-8|22|552|Hyperplastic changes|Lower respiratory system|n/a|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|2|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-9|22|552|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-22|Rn-BN25+250d-WL 500,43-12 10/80|2|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-22-10|22|552|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-1|23|483|Other deterministic changes|Lower respiratory system|n/a|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-2|23|567|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-3|23|579|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-4|23|768|Other deterministic changes|Lower respiratory system|n/a|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-5|23|777|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-6|23|779|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-7|23|846|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|benign,MPATH: 551 - sarcoma|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-8|23|846|Other deterministic changes|Lower respiratory system|n/a|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-9|23|846|Hyperplastic changes|Lower respiratory system|n/a|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|1|77|Rn-222 gas|500|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-10|23|846|Other deterministic changes|Lower respiratory system|n/a|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-1|23|483|Other deterministic changes|Lower respiratory system|n/a|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-2|23|567|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-3|23|579|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-4|23|768|Other deterministic changes|Lower respiratory system|n/a|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-5|23|777|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-6|23|779|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-7|23|846|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|benign,MPATH: 551 - sarcoma|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-8|23|846|Other deterministic changes|Lower respiratory system|n/a|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-9|23|846|Hyperplastic changes|Lower respiratory system|n/a|
2-4-23|Rn-BN25+360d-WL 500,43-13 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-23-10|23|846|Other deterministic changes|Lower respiratory system|n/a|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-1|24|297|Other deterministic changes|Lower respiratory system|n/a|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-2|24|495|Hyperplastic changes|Lower respiratory system|n/a|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-3|24|526|Other deterministic changes|Lower respiratory system|n/a|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-4|24|553|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-5|24|553|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-6|24|553|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-7|24|566|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-8|24|575|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-9|24|593|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-10|24|594|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-11|24|616|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-12|24|626|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-13|24|631|Hyperplastic changes|Lower respiratory system|n/a|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-14|24|638|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-15|24|651|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-16|24|659|Hyperplastic changes|Lower respiratory system|n/a|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-1|24|297|Other deterministic changes|Lower respiratory system|n/a|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-2|24|495|Hyperplastic changes|Lower respiratory system|n/a|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-3|24|526|Other deterministic changes|Lower respiratory system|n/a|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-4|24|553|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-5|24|553|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-6|24|553|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-7|24|566|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-8|24|575|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-9|24|593|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-10|24|594|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-11|24|616|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-12|24|626|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-13|24|631|Hyperplastic changes|Lower respiratory system|n/a|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-14|24|638|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-15|24|651|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-24|Rn-BN3+170d-WL 1000,26-6 4/77|2|247|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-24-16|24|659|Hyperplastic changes|Lower respiratory system|n/a|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-1|25|441|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-2|25|450|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-3|25|450|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-4|25|461|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-5|25|489|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-6|25|491|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-7|25|491|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-8|25|495|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-9|25|510|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-10|25|546|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-11|25|559|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-12|25|578|Other deterministic changes|Whole body|n/a|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-13|25|578|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-14|25|604|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-15|25|609|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-16|25|618|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-1|25|441|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-2|25|450|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-3|25|450|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-4|25|461|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-5|25|489|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-6|25|491|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-7|25|491|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-8|25|495|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-9|25|510|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-10|25|546|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-11|25|559|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-12|25|578|Other deterministic changes|Whole body|n/a|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-13|25|578|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-14|25|604|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-15|25|609|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-25|Rn-BN9+170d-WL 1000,26-7 4/77|2|247|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-25-16|25|618|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-26|Rn-BN25+112d-WL 1000,42-3b 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-26-1|26|287|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-26|Rn-BN25+112d-WL 1000,42-3b 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-26-2|26|287|Hyperplastic changes|Lower respiratory system|n/a|
2-4-26|Rn-BN25+112d-WL 1000,42-3b 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-26-3|26|287|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-26|Rn-BN25+112d-WL 1000,42-3b 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-26-4|26|288|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-26|Rn-BN25+112d-WL 1000,42-3b 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-26-1|26|287|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-26|Rn-BN25+112d-WL 1000,42-3b 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-26-2|26|287|Hyperplastic changes|Lower respiratory system|n/a|
2-4-26|Rn-BN25+112d-WL 1000,42-3b 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-26-3|26|287|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-26|Rn-BN25+112d-WL 1000,42-3b 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-26-4|26|288|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-1|27|399|Other deterministic changes|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-2|27|399|Neoplasia malignant|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-3|27|399|Other deterministic changes|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-4|27|399|Neoplasia benign|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-5|27|406|Hyperplastic changes|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-6|27|406|Other deterministic changes|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-7|27|406|Neoplasia benign|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-8|27|406|Other deterministic changes|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-1|27|399|Other deterministic changes|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-2|27|399|Neoplasia malignant|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-3|27|399|Other deterministic changes|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-4|27|399|Neoplasia benign|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-5|27|406|Hyperplastic changes|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-6|27|406|Other deterministic changes|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-7|27|406|Neoplasia benign|Lower respiratory system|n/a|
2-4-27|Rn-BN25+232d-WL 1000,42-3b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-27-8|27|406|Other deterministic changes|Lower respiratory system|n/a|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-1|28|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-2|28|399|Other deterministic changes|Lower respiratory system|n/a|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-3|28|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-4|28|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-5|28|406|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-6|28|406|Hyperplastic changes|Lower respiratory system|n/a|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-7|28|406|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 0.75 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-8|28|406|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-1|28|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-2|28|399|Other deterministic changes|Lower respiratory system|n/a|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-3|28|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-4|28|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-5|28|406|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-6|28|406|Hyperplastic changes|Lower respiratory system|n/a|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-7|28|406|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-28|Rn-BN25*-232d-WL 1000,42-3c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-28-8|28|406|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-1|29|4|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-2|29|4|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-3|29|11|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-4|29|21|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-5|29|59|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-6|29|68|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-7|29|73|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-8|29|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-9|29|331|Hyperplastic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-10|29|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 3 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-1|29|4|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 3 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-2|29|4|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 3 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-3|29|11|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 3 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-4|29|21|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 3 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-5|29|59|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 3 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-6|29|68|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 3 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-7|29|73|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 3 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-8|29|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 3 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-9|29|331|Hyperplastic changes|Lower respiratory system|n/a|
2-4-29|Rn-BN25+3d-WL 1200,43-21 10/80|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 3 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-29-10|29|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-1|30|236|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-2|30|469|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|metastatic lung tumour,MPATH: 446 - squamous cell carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-3|30|565|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-4|30|567|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-5|30|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-6|30|569|Hyperplastic changes|Lower respiratory system|n/a|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-7|30|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-8|30|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-9|30|569|Hyperplastic changes|Lower respiratory system|n/a|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-10|30|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|metastatic lung tumour,MPATH: 446 - squamous cell carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-1|30|236|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-2|30|469|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|metastatic lung tumour,MPATH: 446 - squamous cell carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-3|30|565|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-4|30|567|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-5|30|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-6|30|569|Hyperplastic changes|Lower respiratory system|n/a|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-7|30|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-8|30|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-9|30|569|Hyperplastic changes|Lower respiratory system|n/a|
2-4-30|Rn-BN25+100d-WL 1200,43-22 10/80|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-30-10|30|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|metastatic lung tumour,MPATH: 446 - squamous cell carcinoma|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-1|31|11|Other deterministic changes|Lower respiratory system|n/a|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-2|31|180|Other deterministic changes|Lower respiratory system|n/a|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-3|31|239|Other deterministic changes|Lower respiratory system|n/a|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-4|31|331|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-5|31|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-6|31|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-7|31|331|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-8|31|331|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-9|31|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-10|31|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-1|31|11|Other deterministic changes|Lower respiratory system|n/a|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-2|31|180|Other deterministic changes|Lower respiratory system|n/a|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-3|31|239|Other deterministic changes|Lower respiratory system|n/a|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-4|31|331|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-5|31|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-6|31|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-7|31|331|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-8|31|331|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-9|31|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-31|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-31-10|31|331|Other deterministic changes|Lower respiratory system|n/a|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-1|32|617|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-2|32|656|Other deterministic changes|Lower respiratory system|n/a|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-3|32|736|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|metastatic lung tumour,MPATH: 446 - squamous cell carcinoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-4|32|790|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-5|32|818|Other deterministic changes|Lower respiratory system|n/a|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-6|32|825|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-7|32|846|Other deterministic changes|Lower respiratory system|n/a|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-8|32|846|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-9|32|846|Neoplasia malignant|Other local manifestations and miscellaneus|benign|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-10|32|846|Neoplasia malignant|Lower respiratory system|n/a|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|2|80|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-1|32|617|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|2|80|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-2|32|656|Other deterministic changes|Lower respiratory system|n/a|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|2|80|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-3|32|736|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|metastatic lung tumour,MPATH: 446 - squamous cell carcinoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|2|80|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-4|32|790|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|2|80|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-5|32|818|Other deterministic changes|Lower respiratory system|n/a|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|2|80|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-6|32|825|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|2|80|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-7|32|846|Other deterministic changes|Lower respiratory system|n/a|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|2|80|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-8|32|846|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|2|80|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-9|32|846|Neoplasia malignant|Other local manifestations and miscellaneus|benign|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|2|80|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-10|32|846|Neoplasia malignant|Lower respiratory system|n/a|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|3|197|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-1|32|617|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|3|197|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-2|32|656|Other deterministic changes|Lower respiratory system|n/a|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|3|197|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-3|32|736|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|metastatic lung tumour,MPATH: 446 - squamous cell carcinoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|3|197|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-4|32|790|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|3|197|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-5|32|818|Other deterministic changes|Lower respiratory system|n/a|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|3|197|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-6|32|825|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|3|197|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-7|32|846|Other deterministic changes|Lower respiratory system|n/a|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|3|197|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-8|32|846|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|3|197|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-9|32|846|Neoplasia malignant|Other local manifestations and miscellaneus|benign|
2-4-32|Rn-BN25+120d-WL 1200,43-31 10/80|3|197|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-32-10|32|846|Neoplasia malignant|Lower respiratory system|n/a|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-1|33|517|Other deterministic changes|Lower respiratory system|n/a|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-2|33|565|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-3|33|686|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-4|33|709|Other deterministic changes|Lower respiratory system|n/a|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-5|33|709|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-6|33|737|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-7|33|737|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|metastatic,MPATH: 278 - follicular adenocarcinoma|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-8|33|747|Other deterministic changes|Whole body|n/a|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-9|33|803|Neoplasia malignant|Lower respiratory system|n/a|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-10|33|846|Hyperplastic changes|Lower respiratory system|n/a|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-1|33|517|Other deterministic changes|Lower respiratory system|n/a|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-2|33|565|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-3|33|686|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-4|33|709|Other deterministic changes|Lower respiratory system|n/a|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-5|33|709|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-6|33|737|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-7|33|737|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|metastatic,MPATH: 278 - follicular adenocarcinoma|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-8|33|747|Other deterministic changes|Whole body|n/a|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-9|33|803|Neoplasia malignant|Lower respiratory system|n/a|
2-4-33|Rn-BN25+360d-WL 1200,43-33 10/80|2|437|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-33-10|33|846|Hyperplastic changes|Lower respiratory system|n/a|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-1|34|569|Other deterministic changes|Lower respiratory system|n/a|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-2|34|569|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-3|34|569|Other deterministic changes|Lower respiratory system|n/a|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-4|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-5|34|569|Other deterministic changes|Lower respiratory system|n/a|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-6|34|569|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-7|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-8|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-9|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|1|77|Rn-222 gas|1200|working level months|Inhalation|inhaled over 1 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-10|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|2|177|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-1|34|569|Other deterministic changes|Lower respiratory system|n/a|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|2|177|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-2|34|569|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|2|177|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-3|34|569|Other deterministic changes|Lower respiratory system|n/a|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|2|177|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-4|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|2|177|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-5|34|569|Other deterministic changes|Lower respiratory system|n/a|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|2|177|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-6|34|569|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|2|177|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-7|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|2|177|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-8|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|2|177|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-9|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|2|177|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-10|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|3|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-1|34|569|Other deterministic changes|Lower respiratory system|n/a|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|3|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-2|34|569|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|3|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-3|34|569|Other deterministic changes|Lower respiratory system|n/a|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|3|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-4|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|3|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-5|34|569|Other deterministic changes|Lower respiratory system|n/a|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|3|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-6|34|569|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|3|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-7|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|3|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-8|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|3|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-9|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-34|Rn-BN6.2+100d-WL 1200,43-32 10/80|3|327|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-34-10|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-4-35|Rn-BN25+112d-WL 15200,42-4a 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-35-1|35|287|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-35|Rn-BN25+112d-WL 15200,42-4a 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-35-2|35|287|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-35|Rn-BN25+112d-WL 15200,42-4a 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-35-3|35|288|Other deterministic changes|Lower respiratory system|n/a|
2-4-35|Rn-BN25+112d-WL 15200,42-4a 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-35-4|35|288|Other deterministic changes|Whole body|n/a|
2-4-35|Rn-BN25+112d-WL 15200,42-4a 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-35-1|35|287|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-35|Rn-BN25+112d-WL 15200,42-4a 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-35-2|35|287|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-35|Rn-BN25+112d-WL 15200,42-4a 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-35-3|35|288|Other deterministic changes|Lower respiratory system|n/a|
2-4-35|Rn-BN25+112d-WL 15200,42-4a 10/80|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-35-4|35|288|Other deterministic changes|Whole body|n/a|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-1|36|399|Neoplasia malignant|Lower respiratory system|n/a|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-2|36|399|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-3|36|399|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-4|36|399|Other deterministic changes|Lower respiratory system|n/a|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-5|36|406|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-6|36|406|Other deterministic changes|Lower respiratory system|n/a|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-7|36|406|Other deterministic changes|Whole body|n/a|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-8|36|406|Other deterministic changes|Lower respiratory system|n/a|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-1|36|399|Neoplasia malignant|Lower respiratory system|n/a|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-2|36|399|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-3|36|399|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-4|36|399|Other deterministic changes|Lower respiratory system|n/a|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-5|36|406|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-6|36|406|Other deterministic changes|Lower respiratory system|n/a|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-7|36|406|Other deterministic changes|Whole body|n/a|
2-4-36|Rn-BN25+232d-WL 1500,42-4b 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-36-8|36|406|Other deterministic changes|Lower respiratory system|n/a|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-1|37|352|Other deterministic changes|Lower respiratory system|n/a|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-2|37|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-3|37|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-4|37|399|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-5|37|399|Other deterministic changes|Lower respiratory system|n/a|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-6|37|406|Other deterministic changes|Whole body|n/a|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-7|37|406|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-8|37|406|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-1|37|352|Other deterministic changes|Lower respiratory system|n/a|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-2|37|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-3|37|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-4|37|399|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-5|37|399|Other deterministic changes|Lower respiratory system|n/a|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-6|37|406|Other deterministic changes|Whole body|n/a|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-7|37|406|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-37|Rn-BN25*+232d-WL 1500,42-4c 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-37-8|37|406|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-1|38|379|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-2|38|559|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-3|38|580|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-4|38|580|Neoplasia malignant|Lower respiratory system|n/a|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-5|38|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-6|38|588|Hyperplastic changes|Lower respiratory system|n/a|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-7|38|590|Hyperplastic changes|Lower respiratory system|n/a|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-8|38|590|Hyperplastic changes|Lower respiratory system|n/a|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-1|38|379|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-2|38|559|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-3|38|580|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-4|38|580|Neoplasia malignant|Lower respiratory system|n/a|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-5|38|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-6|38|588|Hyperplastic changes|Lower respiratory system|n/a|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-7|38|590|Hyperplastic changes|Lower respiratory system|n/a|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|2|309|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-8|38|590|Hyperplastic changes|Lower respiratory system|n/a|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|3|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-1|38|379|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|3|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-2|38|559|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|3|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-3|38|580|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|3|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-4|38|580|Neoplasia malignant|Lower respiratory system|n/a|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|3|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-5|38|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|3|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-6|38|588|Hyperplastic changes|Lower respiratory system|n/a|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|3|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-7|38|590|Hyperplastic changes|Lower respiratory system|n/a|
2-4-38|Rn-BN25#+232d-WL 1500,42-5 10/80|3|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-38-8|38|590|Hyperplastic changes|Lower respiratory system|n/a|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-1|39|580|Hyperplastic changes|Lower respiratory system|n/a|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-2|39|580|Hyperplastic changes|Lower respiratory system|n/a|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-3|39|580|Other deterministic changes|Lower respiratory system|n/a|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-4|39|580|Hyperplastic changes|Lower respiratory system|n/a|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-5|39|588|Hyperplastic changes|Lower respiratory system|n/a|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-6|39|588|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-7|39|590|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-8|39|590|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|2|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-1|39|580|Hyperplastic changes|Lower respiratory system|n/a|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|2|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-2|39|580|Hyperplastic changes|Lower respiratory system|n/a|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|2|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-3|39|580|Other deterministic changes|Lower respiratory system|n/a|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|2|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-4|39|580|Hyperplastic changes|Lower respiratory system|n/a|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|2|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-5|39|588|Hyperplastic changes|Lower respiratory system|n/a|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|2|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-6|39|588|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|2|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-7|39|590|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-39|Rn-BN25+423d-WL 1500,42-6 10/80|2|500|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-39-8|39|590|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-1|40|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-2|40|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-3|40|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-4|40|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-5|40|589|Hyperplastic changes|Lower respiratory system|n/a|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-6|40|589|Hyperplastic changes|Lower respiratory system|n/a|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-7|40|590|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-8|40|590|Hyperplastic changes|Lower respiratory system|n/a|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|2|500|BNF ß-naphtoflavone|1|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-1|40|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|2|500|BNF ß-naphtoflavone|1|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-2|40|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|2|500|BNF ß-naphtoflavone|1|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-3|40|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|2|500|BNF ß-naphtoflavone|1|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-4|40|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|2|500|BNF ß-naphtoflavone|1|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-5|40|589|Hyperplastic changes|Lower respiratory system|n/a|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|2|500|BNF ß-naphtoflavone|1|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-6|40|589|Hyperplastic changes|Lower respiratory system|n/a|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|2|500|BNF ß-naphtoflavone|1|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-7|40|590|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-40|Rn-BN25*+423d-WL 1500,42-7 10/80|2|500|BNF ß-naphtoflavone|1|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-40-8|40|590|Hyperplastic changes|Lower respiratory system|n/a|
2-4-41|Rn-BN25+300d-WL 2000,4/84|1|77|Rn-222 gas|1600|working level months|Inhalation|inhaled over 2 m at 3000 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-41-1|41|36|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-41|Rn-BN25+300d-WL 2000,4/84|1|77|Rn-222 gas|1600|working level months|Inhalation|inhaled over 2 m at 3000 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-41-2|41|36|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-41|Rn-BN25+300d-WL 2000,4/84|1|77|Rn-222 gas|1600|working level months|Inhalation|inhaled over 2 m at 3000 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-41-3|41|36|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-41|Rn-BN25+300d-WL 2000,4/84|1|77|Rn-222 gas|1600|working level months|Inhalation|inhaled over 2 m at 3000 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-41-4|41|36|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-41|Rn-BN25+300d-WL 2000,4/84|2|377|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-41-1|41|36|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-41|Rn-BN25+300d-WL 2000,4/84|2|377|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-41-2|41|36|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-41|Rn-BN25+300d-WL 2000,4/84|2|377|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-41-3|41|36|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-41|Rn-BN25+300d-WL 2000,4/84|2|377|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-41-4|41|36|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-1|42|362|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-2|42|483|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-3|42|530|Other deterministic changes|Lower respiratory system|n/a|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-4|42|550|Neoplasia malignant|Lower respiratory system|n/a|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-5|42|621|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-6|42|629|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-7|42|633|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-8|42|686|Hyperplastic changes|Lower respiratory system|n/a|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-9|42|701|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-10|42|814|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-11|42|822|Other deterministic changes|Lower respiratory system|n/a|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-12|42|824|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-13|42|880|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-14|42|887|Other deterministic changes|Lower respiratory system|n/a|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-15|42|892|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-16|42|994|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-1|42|362|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-2|42|483|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-3|42|530|Other deterministic changes|Lower respiratory system|n/a|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-4|42|550|Neoplasia malignant|Lower respiratory system|n/a|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-5|42|621|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-6|42|629|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-7|42|633|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-8|42|686|Hyperplastic changes|Lower respiratory system|n/a|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-9|42|701|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-10|42|814|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-11|42|822|Other deterministic changes|Lower respiratory system|n/a|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-12|42|824|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-13|42|880|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-14|42|887|Other deterministic changes|Lower respiratory system|n/a|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-15|42|892|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-4-42|Rn-BNp3+112d-WL 1960,33-2 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-42-16|42|994|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-1|43|462|Neoplasia benign|Lower respiratory system|n/a|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-2|43|485|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-3|43|504|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-4|43|518|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-5|43|537|Hyperplastic changes|Lower respiratory system|n/a|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-6|43|573|Neoplasia malignant|Lower respiratory system|n/a|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-7|43|603|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-8|43|632|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-9|43|677|Other deterministic changes|Lower respiratory system|n/a|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-10|43|695|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-11|43|714|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-12|43|761|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-13|43|784|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-14|43|852|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|benign,MPATH: 549 - carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-15|43|855|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-16|43|952|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-1|43|462|Neoplasia benign|Lower respiratory system|n/a|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-2|43|485|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-3|43|504|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-4|43|518|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-5|43|537|Hyperplastic changes|Lower respiratory system|n/a|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-6|43|573|Neoplasia malignant|Lower respiratory system|n/a|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-7|43|603|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-8|43|632|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-9|43|677|Other deterministic changes|Lower respiratory system|n/a|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-10|43|695|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-11|43|714|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-12|43|761|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-13|43|784|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-14|43|852|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|benign,MPATH: 549 - carcinoma|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-15|43|855|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-43|Rn-BNp9+112d-WL 1960,33-3 12/78|2|189|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-43-16|43|952|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-1|44|490|Other deterministic changes|Lower respiratory system|n/a|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-2|44|586|Hyperplastic changes|Lower respiratory system|n/a|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-3|44|586|Other deterministic changes|Lower respiratory system|n/a|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-4|44|590|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-5|44|621|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-6|44|670|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-7|44|739|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-8|44|741|Neoplasia benign|Lower respiratory system|n/a|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|2 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-1|44|490|Other deterministic changes|Lower respiratory system|n/a|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|2 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-2|44|586|Hyperplastic changes|Lower respiratory system|n/a|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|2 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-3|44|586|Other deterministic changes|Lower respiratory system|n/a|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|2 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-4|44|590|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|2 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-5|44|621|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|2 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-6|44|670|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|2 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-7|44|739|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-44|Rn-BNp25+112d-WL 1960,33-9 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|2 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-44-8|44|741|Neoplasia benign|Lower respiratory system|n/a|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-1|45|373|Other deterministic changes|Lower respiratory system|n/a|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-2|45|430|Other deterministic changes|Lower respiratory system|n/a|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-3|45|530|Neoplasia malignant|Reproductive system,MA: 0000410 - seminal vesicle|,MPATH: 268 - adenocarcinoma|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-4|45|767|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-5|45|792|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-6|45|821|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-7|45|951|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-8|45|960|Hyperplastic changes|Lower respiratory system|n/a|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|4 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-1|45|373|Other deterministic changes|Lower respiratory system|n/a|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|4 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-2|45|430|Other deterministic changes|Lower respiratory system|n/a|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|4 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-3|45|530|Neoplasia malignant|Reproductive system,MA: 0000410 - seminal vesicle|,MPATH: 268 - adenocarcinoma|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|4 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-4|45|767|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|4 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-5|45|792|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|4 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-6|45|821|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|4 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-7|45|951|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-45|Rn-BNp25*+112d-WL 1960,33-8 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|4 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-45-8|45|960|Hyperplastic changes|Lower respiratory system|n/a|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-1|46|240|Other deterministic changes|Whole body|n/a|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-2|46|259|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-3|46|267|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-4|46|267|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-5|46|273|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-6|46|273|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-7|46|275|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-8|46|275|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-9|46|285|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-10|46|289|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-11|46|315|Neoplasia malignant|Lower respiratory system|n/a|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-12|46|315|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-13|46|358|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-14|46|358|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-15|46|483|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-16|46|483|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-1|46|240|Other deterministic changes|Whole body|n/a|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-2|46|259|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-3|46|267|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-4|46|267|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-5|46|273|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-6|46|273|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-7|46|275|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-8|46|275|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-9|46|285|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-10|46|289|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-11|46|315|Neoplasia malignant|Lower respiratory system|n/a|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-12|46|315|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-13|46|358|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-14|46|358|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-15|46|483|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-46|Rn-BNp25#+112d-WL 1960,33-4 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-46-16|46|483|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-1|47|275|Other deterministic changes|Lower respiratory system|n/a|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-2|47|602|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-3|47|673|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-4|47|701|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|metastatic,MPATH: 218 - neoplasm|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-5|47|768|Hyperplastic changes|Lower respiratory system|n/a|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-6|47|792|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-7|47|836|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-8|47|853|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-9|47|912|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-10|47|961|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intratracheal|4 Intratracheal inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-1|47|275|Other deterministic changes|Lower respiratory system|n/a|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intratracheal|4 Intratracheal inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-2|47|602|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intratracheal|4 Intratracheal inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-3|47|673|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intratracheal|4 Intratracheal inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-4|47|701|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|metastatic,MPATH: 218 - neoplasm|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intratracheal|4 Intratracheal inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-5|47|768|Hyperplastic changes|Lower respiratory system|n/a|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intratracheal|4 Intratracheal inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-6|47|792|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intratracheal|4 Intratracheal inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-7|47|836|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intratracheal|4 Intratracheal inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-8|47|853|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intratracheal|4 Intratracheal inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-9|47|912|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-4-47|Rn-BNt25+112d-WL 1960,33-7 12/78|2|189|BNF ß-naphtoflavone|3|milligrams per kg animal|Injection, intratracheal|4 Intratracheal inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-47-10|47|961|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-1|48|232|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-2|48|247|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-3|48|259|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|metastatic,MPATH: 408 - soft tissue fibrosarcoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-4|48|261|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-5|48|269|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-6|48|269|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-7|48|275|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-8|48|296|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-9|48|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-10|48|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-1|48|232|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-2|48|247|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-3|48|259|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|metastatic,MPATH: 408 - soft tissue fibrosarcoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-4|48|261|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-5|48|269|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-6|48|269|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-7|48|275|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-8|48|296|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-9|48|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-48|Rn-BN25m+112d-WL 1960,33-6 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-48-10|48|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-1|49|352|Other deterministic changes|Lower respiratory system|n/a|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-2|49|438|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-3|49|523|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-4|49|625|Other deterministic changes|Lower respiratory system|n/a|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-5|49|667|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-6|49|714|Neoplasia malignant|Lower respiratory system|n/a|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-7|49|785|Other deterministic changes|Lower respiratory system|n/a|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-8|49|800|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-9|49|843|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|1|77|Rn-222 gas|1960|working level months|Inhalation|inhaled over 2 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-10|49|908|Neoplasia malignant|Nervous system and special sense organs,MA: 0000236 - ear|,MPATH: 218 - neoplasm|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Gavage|12 oral gavage 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-1|49|352|Other deterministic changes|Lower respiratory system|n/a|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Gavage|12 oral gavage 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-2|49|438|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Gavage|12 oral gavage 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-3|49|523|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Gavage|12 oral gavage 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-4|49|625|Other deterministic changes|Lower respiratory system|n/a|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Gavage|12 oral gavage 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-5|49|667|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Gavage|12 oral gavage 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-6|49|714|Neoplasia malignant|Lower respiratory system|n/a|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Gavage|12 oral gavage 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-7|49|785|Other deterministic changes|Lower respiratory system|n/a|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Gavage|12 oral gavage 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-8|49|800|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Gavage|12 oral gavage 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-9|49|843|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-49|Rn-BNo25+112d-WL 1960,33-5 12/78|2|189|BNF ß-naphtoflavone|25|milligrams per kg animal|Gavage|12 oral gavage 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-49-10|49|908|Neoplasia malignant|Nervous system and special sense organs,MA: 0000236 - ear|,MPATH: 218 - neoplasm|
2-4-50|Rn-BN6.2+60d-WL 2000,44-1 10/80|1|365|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-50-1|50|55|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-50|Rn-BN6.2+60d-WL 2000,44-1 10/80|1|365|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-50-2|50|57|Other deterministic changes|Lower respiratory system|n/a|
2-4-50|Rn-BN6.2+60d-WL 2000,44-1 10/80|1|365|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-50-3|50|469|Other deterministic changes|Lower respiratory system|n/a|
2-4-50|Rn-BN6.2+60d-WL 2000,44-1 10/80|1|365|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-50-4|50|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-50|Rn-BN6.2+60d-WL 2000,44-1 10/80|2|425|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-50-1|50|55|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-50|Rn-BN6.2+60d-WL 2000,44-1 10/80|2|425|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-50-2|50|57|Other deterministic changes|Lower respiratory system|n/a|
2-4-50|Rn-BN6.2+60d-WL 2000,44-1 10/80|2|425|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-50-3|50|469|Other deterministic changes|Lower respiratory system|n/a|
2-4-50|Rn-BN6.2+60d-WL 2000,44-1 10/80|2|425|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-50-4|50|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-51|Rn-BN6.2*+60d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-51-1|51|211|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-51|Rn-BN6.2*+60d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-51-2|51|226|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-51|Rn-BN6.2*+60d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-51-3|51|226|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-51|Rn-BN6.2*+60d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-51-4|51|244|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-51|Rn-BN6.2*+60d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-51-5|51|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-51|Rn-BN6.2*+60d-WL 2000,44-1 10/80|2|37|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|16 IM inject. 7 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-51-1|51|211|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-51|Rn-BN6.2*+60d-WL 2000,44-1 10/80|2|37|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|16 IM inject. 7 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-51-2|51|226|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-51|Rn-BN6.2*+60d-WL 2000,44-1 10/80|2|37|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|16 IM inject. 7 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-51-3|51|226|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-51|Rn-BN6.2*+60d-WL 2000,44-1 10/80|2|37|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|16 IM inject. 7 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-51-4|51|244|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-51|Rn-BN6.2*+60d-WL 2000,44-1 10/80|2|37|BNF ß-naphtoflavone|6.25|milligrams per kg animal|Injection, intramuscular|16 IM inject. 7 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-51-5|51|310|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-1|52|194|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-2|52|194|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-3|52|208|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-4|52|215|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-5|52|222|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-6|52|224|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-7|52|230|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-8|52|247|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-9|52|250|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-10|52|253|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-11|52|261|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-12|52|274|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-13|52|287|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-14|52|307|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-15|52|337|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|1|77|Rn-222 gas|2000|working level months|Inhalation|inhaled over 1.5 m at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-16|52|398|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-1|52|194|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-2|52|194|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-3|52|208|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-4|52|215|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-5|52|222|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-6|52|224|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-7|52|230|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-8|52|247|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-9|52|250|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-10|52|253|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-11|52|261|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-12|52|274|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-13|52|287|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-14|52|307|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-15|52|337|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|2|140|BNF ß-naphtoflavone|6|milligrams per kg animal|Injection, intramuscular|4 IM inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-16|52|398|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-1|52|194|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-2|52|194|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-3|52|208|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-4|52|215|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-5|52|222|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-6|52|224|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-7|52|230|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-8|52|247|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-9|52|250|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-10|52|253|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-11|52|261|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-12|52|274|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-13|52|287|Other deterministic changes|Lower respiratory system|n/a|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-14|52|307|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-15|52|337|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-52|Rn-BN6+63d-WL 2000,44-1 10/80|3|184|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|4 IM inject. 15 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-52-16|52|398|Other deterministic changes|Lower respiratory system|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-1|53|21|Other deterministic changes|Lower respiratory system|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-2|53|27|Other deterministic changes|Whole body|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-3|53|36|Other deterministic changes|Lower respiratory system|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-4|53|36|Other deterministic changes|Lower respiratory system|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-5|53|36|Other deterministic changes|Lower respiratory system|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-6|53|49|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-7|53|49|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-8|53|49|Other deterministic changes|Lower respiratory system|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-9|53|49|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-10|53|63|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6-12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-1|53|21|Other deterministic changes|Lower respiratory system|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6-12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-2|53|27|Other deterministic changes|Whole body|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6-12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-3|53|36|Other deterministic changes|Lower respiratory system|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6-12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-4|53|36|Other deterministic changes|Lower respiratory system|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6-12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-5|53|36|Other deterministic changes|Lower respiratory system|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6-12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-6|53|49|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6-12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-7|53|49|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6-12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-8|53|49|Other deterministic changes|Lower respiratory system|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6-12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-9|53|49|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-53|Rn-BNm25+3d-WL 2100,40-1 10/79|2|80|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|6-12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-53-10|53|63|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-54|Rn-BNp25+100d-WL 2100,20-9 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-54-1|54|282|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-54|Rn-BNp25+100d-WL 2100,20-9 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-54-2|54|311|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-54|Rn-BNp25+100d-WL 2100,20-9 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-54-3|54|315|Other deterministic changes|Lower respiratory system|n/a|
2-4-54|Rn-BNp25+100d-WL 2100,20-9 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-54-4|54|315|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-54|Rn-BNp25+100d-WL 2100,20-9 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-54-5|54|379|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-54|Rn-BNp25+100d-WL 2100,20-9 1/76|2|240|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 15 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-54-1|54|282|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-54|Rn-BNp25+100d-WL 2100,20-9 1/76|2|240|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 15 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-54-2|54|311|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-54|Rn-BNp25+100d-WL 2100,20-9 1/76|2|240|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 15 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-54-3|54|315|Other deterministic changes|Lower respiratory system|n/a|
2-4-54|Rn-BNp25+100d-WL 2100,20-9 1/76|2|240|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 15 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-54-4|54|315|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-54|Rn-BNp25+100d-WL 2100,20-9 1/76|2|240|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 15 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-54-5|54|379|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-55|Rn-BNm25+100d-WL 2100,40-2 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-55-1|55|216|Neoplasia benign|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-4-55|Rn-BNm25+100d-WL 2100,40-2 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-55-2|55|266|Neoplasia benign|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-4-55|Rn-BNm25+100d-WL 2100,40-2 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-55-3|55|266|Other deterministic changes|Lower respiratory system|n/a|
2-4-55|Rn-BNm25+100d-WL 2100,40-2 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-55-4|55|350|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-55|Rn-BNm25+100d-WL 2100,40-2 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-55-5|55|350|Hyperplastic changes|Lower respiratory system|n/a|
2-4-55|Rn-BNm25+100d-WL 2100,40-2 10/79|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-55-1|55|216|Neoplasia benign|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-4-55|Rn-BNm25+100d-WL 2100,40-2 10/79|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-55-2|55|266|Neoplasia benign|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-4-55|Rn-BNm25+100d-WL 2100,40-2 10/79|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-55-3|55|266|Other deterministic changes|Lower respiratory system|n/a|
2-4-55|Rn-BNm25+100d-WL 2100,40-2 10/79|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-55-4|55|350|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-55|Rn-BNm25+100d-WL 2100,40-2 10/79|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-55-5|55|350|Hyperplastic changes|Lower respiratory system|n/a|
2-4-56|Rn-BNm25*+100d-WL 2100,403 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-56-1|56|238|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-56|Rn-BNm25*+100d-WL 2100,403 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-56-2|56|258|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-56|Rn-BNm25*+100d-WL 2100,403 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-56-3|56|259|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-56|Rn-BNm25*+100d-WL 2100,403 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-56-4|56|339|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-56|Rn-BNm25*+100d-WL 2100,403 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-56-5|56|350|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-56|Rn-BNm25*+100d-WL 2100,403 10/79|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 7 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-56-1|56|238|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-56|Rn-BNm25*+100d-WL 2100,403 10/79|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 7 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-56-2|56|258|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-56|Rn-BNm25*+100d-WL 2100,403 10/79|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 7 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-56-3|56|259|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-56|Rn-BNm25*+100d-WL 2100,403 10/79|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 7 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-56-4|56|339|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-56|Rn-BNm25*+100d-WL 2100,403 10/79|2|177|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|2 IM inject. 7 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-56-5|56|350|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-1|57|381|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-2|57|385|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-3|57|387|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-4|57|389|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-5|57|389|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-6|57|389|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-7|57|389|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-8|57|392|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-9|57|392|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-10|57|392|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-11|57|392|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-12|57|393|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-13|57|406|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-14|57|419|Other deterministic changes|Whole body|n/a|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-15|57|426|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-16|57|434|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-17|57|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-18|57|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-19|57|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-20|57|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-1|57|381|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-2|57|385|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-3|57|387|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-4|57|389|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-5|57|389|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-6|57|389|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-7|57|389|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-8|57|392|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-9|57|392|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-10|57|392|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-11|57|392|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-12|57|393|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-13|57|406|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-14|57|419|Other deterministic changes|Whole body|n/a|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-15|57|426|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-16|57|434|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-17|57|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-18|57|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-19|57|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-57|Rn-BNp25+140d-WL 2100,20-1 10/76|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|3 IP inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-57-20|57|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-1|58|153|Other deterministic changes|Whole body|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-2|58|166|Other deterministic changes|Whole body|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-3|58|182|Other deterministic changes|Whole body|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-4|58|185|Other deterministic changes|Whole body|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-5|58|191|Other deterministic changes|Whole body|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-6|58|213|Other deterministic changes|Whole body|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-7|58|219|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-8|58|224|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-9|58|225|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-10|58|231|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-11|58|231|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-12|58|236|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-13|58|238|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-14|58|309|Other deterministic changes|Lower respiratory system|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-15|58|310|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-16|58|311|Other deterministic changes|Lower respiratory system|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-17|58|312|Other deterministic changes|Lower respiratory system|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-1|58|153|Other deterministic changes|Whole body|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-2|58|166|Other deterministic changes|Whole body|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-3|58|182|Other deterministic changes|Whole body|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-4|58|185|Other deterministic changes|Whole body|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-5|58|191|Other deterministic changes|Whole body|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-6|58|213|Other deterministic changes|Whole body|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-7|58|219|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-8|58|224|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-9|58|225|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-10|58|231|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-11|58|231|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-12|58|236|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-13|58|238|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-14|58|309|Other deterministic changes|Lower respiratory system|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-15|58|310|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-16|58|311|Other deterministic changes|Lower respiratory system|n/a|
2-4-58|Rn-BNm25+140d-WL 2100,48-1 2/81|2|259|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|1(2) IM inject.|17 (17 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-58-17|58|312|Other deterministic changes|Lower respiratory system|n/a|
2-4-59|Rn-BNm9+217d-WL 2100,40-5 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-59-1|59|369|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-59|Rn-BNm9+217d-WL 2100,40-5 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-59-2|59|379|Neoplasia benign|Lower respiratory system|n/a|
2-4-59|Rn-BNm9+217d-WL 2100,40-5 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-59-3|59|379|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-59|Rn-BNm9+217d-WL 2100,40-5 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-59-4|59|379|Neoplasia malignant|Lower respiratory system|n/a|
2-4-59|Rn-BNm9+217d-WL 2100,40-5 10/79|2|294|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intramuscular|3 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-59-1|59|369|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-59|Rn-BNm9+217d-WL 2100,40-5 10/79|2|294|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intramuscular|3 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-59-2|59|379|Neoplasia benign|Lower respiratory system|n/a|
2-4-59|Rn-BNm9+217d-WL 2100,40-5 10/79|2|294|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intramuscular|3 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-59-3|59|379|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-59|Rn-BNm9+217d-WL 2100,40-5 10/79|2|294|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intramuscular|3 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-59-4|59|379|Neoplasia malignant|Lower respiratory system|n/a|
2-4-60|Rn-BNm9+217d-WL 2100,40-4 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-60-1|60|425|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-60|Rn-BNm9+217d-WL 2100,40-4 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-60-2|60|448|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-60|Rn-BNm9+217d-WL 2100,40-4 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-60-3|60|448|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-60|Rn-BNm9+217d-WL 2100,40-4 10/79|1|77|Rn-222 gas|2100|working level months|Inhalation|inhaled over 3 m at 1050 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-60-4|60|448|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-60|Rn-BNm9+217d-WL 2100,40-4 10/79|2|294|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intramuscular|5 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-60-1|60|425|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-60|Rn-BNm9+217d-WL 2100,40-4 10/79|2|294|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intramuscular|5 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-60-2|60|448|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-60|Rn-BNm9+217d-WL 2100,40-4 10/79|2|294|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intramuscular|5 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-60-3|60|448|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-60|Rn-BNm9+217d-WL 2100,40-4 10/79|2|294|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intramuscular|5 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-60-4|60|448|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-1|61|473|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-2|61|479|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-3|61|491|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-4|61|505|Neoplasia malignant|Lower respiratory system|n/a|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-5|61|568|Other deterministic changes|Lower respiratory system|n/a|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-6|61|568|Other deterministic changes|Lower respiratory system|n/a|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-7|61|653|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-8|61|653|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|2|435|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|6 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-1|61|473|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|2|435|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|6 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-2|61|479|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|2|435|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|6 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-3|61|491|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|2|435|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|6 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-4|61|505|Neoplasia malignant|Lower respiratory system|n/a|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|2|435|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|6 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-5|61|568|Other deterministic changes|Lower respiratory system|n/a|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|2|435|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|6 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-6|61|568|Other deterministic changes|Lower respiratory system|n/a|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|2|435|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|6 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-7|61|653|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-61|Rn-BNp25+280d-WL 2100,20-2 1/76|2|435|BNF ß-naphtoflavone|9|milligrams per kg animal|Injection, intraperitoneal|6 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-61-8|61|653|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-1|62|683|Other deterministic changes|Lower respiratory system|n/a|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-2|62|697|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-3|62|701|Other deterministic changes|Lower respiratory system|n/a|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-4|62|757|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-5|62|761|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-6|62|764|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-7|62|764|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled over 2 m at 1050 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-8|62|764|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|2|655|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|13 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-1|62|683|Other deterministic changes|Lower respiratory system|n/a|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|2|655|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|13 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-2|62|697|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|2|655|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|13 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-3|62|701|Other deterministic changes|Lower respiratory system|n/a|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|2|655|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|13 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-4|62|757|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|2|655|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|13 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-5|62|761|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|2|655|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|13 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-6|62|764|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|2|655|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|13 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-7|62|764|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-62|Rn-BNp25+500d-WL 2100,20-4 1/76|2|655|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|13 IP inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-62-8|62|764|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-1|63|208|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-2|63|220|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-3|63|261|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-4|63|264|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-5|63|269|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-6|63|269|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-7|63|286|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-8|63|297|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-9|63|297|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-10|63|297|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|2|172|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-1|63|208|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|2|172|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-2|63|220|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|2|172|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-3|63|261|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|2|172|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-4|63|264|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|2|172|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-5|63|269|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|2|172|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-6|63|269|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|2|172|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-7|63|286|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|2|172|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-8|63|297|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|2|172|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-9|63|297|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-63|Rn-BN25+95d-WL 2240,36 4/79|2|172|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|12 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-63-10|63|297|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-64|Rn-BN25+176d-WL 2240,36-2 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-64-1|64|325|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-64|Rn-BN25+176d-WL 2240,36-2 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-64-2|64|371|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-64|Rn-BN25+176d-WL 2240,36-2 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-64-3|64|373|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-64|Rn-BN25+176d-WL 2240,36-2 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-64-4|64|373|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-64|Rn-BN25+176d-WL 2240,36-2 4/79|2|253|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-64-1|64|325|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-64|Rn-BN25+176d-WL 2240,36-2 4/79|2|253|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-64-2|64|371|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-64|Rn-BN25+176d-WL 2240,36-2 4/79|2|253|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-64-3|64|373|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-64|Rn-BN25+176d-WL 2240,36-2 4/79|2|253|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|3 IM inject. 30 d interval|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-64-4|64|373|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-1|65|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-2|65|433|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-3|65|444|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-4|65|451|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-5|65|462|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-6|65|475|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-7|65|475|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-8|65|511|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-9|65|524|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-10|65|650|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|2|357|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|5 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-1|65|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|2|357|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|5 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-2|65|433|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|2|357|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|5 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-3|65|444|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|2|357|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|5 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-4|65|451|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|2|357|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|5 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-5|65|462|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|2|357|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|5 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-6|65|475|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|2|357|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|5 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-7|65|475|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|2|357|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|5 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-8|65|511|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|2|357|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|5 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-9|65|524|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-65|Rn-BN25+280d-WL 2240,36 4/79|2|357|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intramuscular|5 IM inject. 7 d interval|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-65-10|65|650|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|1|77|Rn-222 gas|4200|working level months|Inhalation|inhaled over 2 m at 2255 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-1|66|272|Other deterministic changes|Lower respiratory system|n/a|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|1|77|Rn-222 gas|4200|working level months|Inhalation|inhaled over 2 m at 2255 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-2|66|272|Other deterministic changes|Lower respiratory system|n/a|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|1|77|Rn-222 gas|4200|working level months|Inhalation|inhaled over 2 m at 2255 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-3|66|503|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|1|77|Rn-222 gas|4200|working level months|Inhalation|inhaled over 2 m at 2255 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-4|66|536|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|1|77|Rn-222 gas|4200|working level months|Inhalation|inhaled over 2 m at 2255 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-5|66|551|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|1|77|Rn-222 gas|4200|working level months|Inhalation|inhaled over 2 m at 2255 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-6|66|648|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|1|77|Rn-222 gas|4200|working level months|Inhalation|inhaled over 2 m at 2255 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-7|66|651|Neoplasia benign|Lower respiratory system|n/a|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|1|77|Rn-222 gas|4200|working level months|Inhalation|inhaled over 2 m at 2255 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-8|66|671|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|1|77|Rn-222 gas|4200|working level months|Inhalation|inhaled over 2 m at 2255 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-9|66|724|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|1|77|Rn-222 gas|4200|working level months|Inhalation|inhaled over 2 m at 2255 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-10|66|779|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|2|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval ? -82 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-1|66|272|Other deterministic changes|Lower respiratory system|n/a|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|2|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval ? -82 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-2|66|272|Other deterministic changes|Lower respiratory system|n/a|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|2|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval ? -82 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-3|66|503|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|2|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval ? -82 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-4|66|536|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|2|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval ? -82 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-5|66|551|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|2|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval ? -82 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-6|66|648|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|2|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval ? -82 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-7|66|651|Neoplasia benign|Lower respiratory system|n/a|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|2|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval ? -82 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-8|66|671|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|2|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval ? -82 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-9|66|724|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-66|Rn-BN25-82d-WL 4200,35 3/79|2|77|BNF ß-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval ? -82 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-66-10|66|779|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-1|67|384|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-2|67|486|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-3|67|492|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-4|67|570|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-5|67|584|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-6|67|591|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-7|67|600|Neoplasia malignant|Lymphatic vessels among cardiovascular system|n/a|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|1|77|Rn-222 gas|1000|working level months|Inhalation|inhaled over 1.5 m at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-8|67|652|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|2|247|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-1|67|384|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|2|247|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-2|67|486|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|2|247|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-3|67|492|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|2|247|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-4|67|570|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|2|247|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-5|67|584|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|2|247|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-6|67|591|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|2|247|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-7|67|600|Neoplasia malignant|Lymphatic vessels among cardiovascular system|n/a|
2-4-67|Rn-aBF25+170dWL 1000,28-6 4/77|2|247|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-67-8|67|652|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-1|68|253|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-2|68|511|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-3|68|589|Neoplasia malignant|Reproductive system,MA: 0000410 - seminal vesicle|,MPATH: 268 - adenocarcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-4|68|604|Neoplasia malignant|Lower respiratory system|n/a|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-5|68|652|Hyperplastic changes|Lower respiratory system|n/a|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-6|68|669|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-7|68|713|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-8|68|715|Neoplasia malignant|Lower respiratory system|n/a|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-9|68|735|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-10|68|818|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-11|68|879|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|metastatic,MPATH: 278 - follicular adenocarcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-12|68|894|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-13|68|910|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-14|68|910|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-15|68|913|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|1|77|Rn-222 gas|2240|working level months|Inhalation|inhaled over 2.5 m at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-16|68|914|Hyperplastic changes|Lower respiratory system|n/a|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-1|68|253|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-2|68|511|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-3|68|589|Neoplasia malignant|Reproductive system,MA: 0000410 - seminal vesicle|,MPATH: 268 - adenocarcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-4|68|604|Neoplasia malignant|Lower respiratory system|n/a|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-5|68|652|Hyperplastic changes|Lower respiratory system|n/a|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-6|68|669|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-7|68|713|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-8|68|715|Neoplasia malignant|Lower respiratory system|n/a|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-9|68|735|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-10|68|818|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-11|68|879|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|metastatic,MPATH: 278 - follicular adenocarcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-12|68|894|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-13|68|910|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-14|68|910|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-15|68|913|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-68|Rn-aBF25+190d-WL 2240,38-3 4/79|2|267|ANF alpha-naphtoflavone|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-68-16|68|914|Hyperplastic changes|Lower respiratory system|n/a|
2-4-69|Rn-BF+245d-WL 1500,42-9 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-69-1|69|441|Hyperplastic changes|Lower respiratory system|n/a|
2-4-69|Rn-BF+245d-WL 1500,42-9 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-69-2|69|441|Other deterministic changes|Lower respiratory system|n/a|
2-4-69|Rn-BF+245d-WL 1500,42-9 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-69-3|69|441|Neoplasia benign|Lower respiratory system|n/a|
2-4-69|Rn-BF+245d-WL 1500,42-9 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-69-4|69|441|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-4-69|Rn-BF+245d-WL 1500,42-9 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-69-5|69|441|Hyperplastic changes|Lower respiratory system|n/a|
2-4-69|Rn-BF+245d-WL 1500,42-9 10/80|1|77|Rn-222 gas|1500|working level months|Inhalation|inhaled over 1 m at 1500 WL|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-69-6|69|441|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-1|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-2|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-3|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-4|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-5|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-6|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-7|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-8|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-9|70|636|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-10|70|678|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-11|70|678|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-12|70|678|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-13|70|678|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-14|70|678|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-15|70|678|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|1|155|benzopyrene|5|milligrams|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-16|70|678|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-1|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-2|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-3|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-4|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-5|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-6|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-7|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-8|70|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-9|70|636|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-10|70|678|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-11|70|678|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-12|70|678|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-13|70|678|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-14|70|678|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-15|70|678|Other deterministic changes|Lower respiratory system|n/a|
2-4-70|Rn-BP5-WL 0,48 12/81|2|322|bromoflavone||unit code not relevant|Injection, not specified|amount unknown|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-70-16|70|678|Other deterministic changes|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-1|71|313|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-2|71|323|Other deterministic changes|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-3|71|346|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-4|71|371|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-5|71|397|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-6|71|410|Other deterministic changes|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-7|71|439|Other deterministic changes|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-8|71|451|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-9|71|458|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-10|71|467|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-11|71|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-12|71|479|Neoplasia benign|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-13|71|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-14|71|479|Neoplasia malignant|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-15|71|479|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|1|155|Rn-222 gas|225|working level months|Inhalation|inhaled at 1500 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-16|71|479|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-1|71|313|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-2|71|323|Other deterministic changes|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-3|71|346|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-4|71|371|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-5|71|397|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-6|71|410|Other deterministic changes|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-7|71|439|Other deterministic changes|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-8|71|451|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-9|71|458|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-10|71|467|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-11|71|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-12|71|479|Neoplasia benign|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-13|71|479|Other deterministic changes|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-14|71|479|Neoplasia malignant|Lower respiratory system|n/a|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-15|71|479|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-71|Rn-BP5+229d-WL 225,48 12/81|2|385|benzopyrene|5|milligrams per kg animal|Injection, intraperitoneal|IP inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-71-16|71|479|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-1|72|197|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-2|72|202|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-3|72|202|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-4|72|202|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-5|72|204|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-6|72|217|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-7|72|218|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-8|72|222|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-9|72|223|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-10|72|224|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|2|155|benzopyrene|10|milligrams per kg animal|Injection, intratracheal|Intracheal inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-1|72|197|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|2|155|benzopyrene|10|milligrams per kg animal|Injection, intratracheal|Intracheal inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-2|72|202|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|2|155|benzopyrene|10|milligrams per kg animal|Injection, intratracheal|Intracheal inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-3|72|202|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|2|155|benzopyrene|10|milligrams per kg animal|Injection, intratracheal|Intracheal inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-4|72|202|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|2|155|benzopyrene|10|milligrams per kg animal|Injection, intratracheal|Intracheal inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-5|72|204|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|2|155|benzopyrene|10|milligrams per kg animal|Injection, intratracheal|Intracheal inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-6|72|217|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|2|155|benzopyrene|10|milligrams per kg animal|Injection, intratracheal|Intracheal inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-7|72|218|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|2|155|benzopyrene|10|milligrams per kg animal|Injection, intratracheal|Intracheal inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-8|72|222|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|2|155|benzopyrene|10|milligrams per kg animal|Injection, intratracheal|Intracheal inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-9|72|223|Other deterministic changes|Whole body|n/a|
2-4-72|Rn-BP10-WL 1000,27-1 4/77|2|155|benzopyrene|10|milligrams per kg animal|Injection, intratracheal|Intracheal inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-72-10|72|224|Other deterministic changes|Whole body|n/a|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-1|73|298|Other deterministic changes|Lower respiratory system|n/a|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-2|73|356|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-3|73|356|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-4|73|365|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-5|73|365|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-6|73|365|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-7|73|380|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|1|155|Rn-222 gas|1000|working level months|Inhalation|inhaled at 1000 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-8|73|479|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|2|325|benzopyrene|2.5|milligrams per kg animal|Injection, intratracheal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-1|73|298|Other deterministic changes|Lower respiratory system|n/a|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|2|325|benzopyrene|2.5|milligrams per kg animal|Injection, intratracheal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-2|73|356|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|2|325|benzopyrene|2.5|milligrams per kg animal|Injection, intratracheal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-3|73|356|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|2|325|benzopyrene|2.5|milligrams per kg animal|Injection, intratracheal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-4|73|365|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|2|325|benzopyrene|2.5|milligrams per kg animal|Injection, intratracheal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-5|73|365|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|2|325|benzopyrene|2.5|milligrams per kg animal|Injection, intratracheal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-6|73|365|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|2|325|benzopyrene|2.5|milligrams per kg animal|Injection, intratracheal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-7|73|380|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-4-73|Rn-BP2.5+179d-WL 1000,28 4/77|2|325|benzopyrene|2.5|milligrams per kg animal|Injection, intratracheal|12 IP inject. 7 d interval|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-73-8|73|479|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-4-74|Rn-BP15p-8-WL 1600,S51 G1MAV 10/83|1|155|Rn-222 gas|1600|working level months|Inhalation|inhaled at 3000 WL (time of radon exposure not clear for these groups)|45 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|No information on individuals available for this study
2-4-74|Rn-BP15p-8-WL 1600,S51 G1MAV 10/83|2|147|benzopyrene|15|milligrams per kg animal|Injection, intramuscular|IM inject. mothers - 8d fertil.|45 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|No information on individuals available for this study
2-4-75|Rn-BP15p-8-WL 1600,S51 G1FAV 10/83|1|-31|Rn-222 gas|1600|working level months|Inhalation|inhaled at 3000 WL (time of radon exposure not clear for these groups)|51 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|offspring|No information on individuals available for this study
2-4-75|Rn-BP15p-8-WL 1600,S51 G1FAV 10/83|2|-15|benzopyrene|15|milligrams per kg animal|Injection, intramuscular|IM inject. mothers - 8d fertil.|51 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|offspring|No information on individuals available for this study
2-4-76|Rn-BP15p-10-WL 1600,S51 G2MPD 10/83|1|-31|Rn-222 gas|1600|working level months|Inhalation|inhaled at 3000 WL (time of radon exposure not clear for these groups)|75 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|offspring|No information on individuals available for this study
2-4-76|Rn-BP15p-10-WL 1600,S51 G2MPD 10/83|2|-12|benzopyrene|15|milligrams per kg animal|Injection, intramuscular|IM inject. mothers 10 d post fertil.|75 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|offspring|No information on individuals available for this study
2-4-77|Rn-BP15p-10-WL 1600,S51 G2FPD 10/83|1|-10|Rn-222 gas|1600|working level months|Inhalation|inhaled at 3000 WL (time of radon exposure not clear for these groups)|25 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|offspring|No information on individuals available for this study
2-4-77|Rn-BP15p-10-WL 1600,S51 G2FPD 10/83|2|-10|benzopyrene|15|milligrams per kg animal|Injection, intramuscular|IM inject. mothers during pregnancy|25 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|offspring|No information on individuals available for this study
2-4-78|Rn-BP+365-WL 2100,19 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled at 1050 WL|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-78-1|78|541|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-78|Rn-BP+365-WL 2100,19 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled at 1050 WL|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-78-2|78|589|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-4-78|Rn-BP+365-WL 2100,19 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled at 1050 WL|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-78-3|78|639|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-78|Rn-BP+365-WL 2100,19 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled at 1050 WL|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-78-4|78|680|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-4-78|Rn-BP+365-WL 2100,19 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled at 1050 WL|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-78-5|78|716|Neoplasia malignant|Lower respiratory system|n/a|
2-4-78|Rn-BP+365-WL 2100,19 1/76|1|155|Rn-222 gas|2100|working level months|Inhalation|inhaled at 1050 WL|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-78-6|78|716|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-78|Rn-BP+365-WL 2100,19 1/76|2|520|benzopyrene|15|milligrams per kg animal|Injection, intramuscular|IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-78-1|78|541|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-78|Rn-BP+365-WL 2100,19 1/76|2|520|benzopyrene|15|milligrams per kg animal|Injection, intramuscular|IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-78-2|78|589|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-4-78|Rn-BP+365-WL 2100,19 1/76|2|520|benzopyrene|15|milligrams per kg animal|Injection, intramuscular|IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-78-3|78|639|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-4-78|Rn-BP+365-WL 2100,19 1/76|2|520|benzopyrene|15|milligrams per kg animal|Injection, intramuscular|IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-78-4|78|680|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-4-78|Rn-BP+365-WL 2100,19 1/76|2|520|benzopyrene|15|milligrams per kg animal|Injection, intramuscular|IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-78-5|78|716|Neoplasia malignant|Lower respiratory system|n/a|
2-4-78|Rn-BP+365-WL 2100,19 1/76|2|520|benzopyrene|15|milligrams per kg animal|Injection, intramuscular|IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-78-6|78|716|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-1|79|241|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-2|79|256|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|benign,MPATH: 551 - sarcoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-3|79|283|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-4|79|294|Other deterministic changes|Lower respiratory system|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-5|79|317|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-6|79|323|Other deterministic changes|Lower respiratory system|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-7|79|328|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-8|79|328|Neoplasia malignant|Lower respiratory system|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-9|79|330|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-10|79|331|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-11|79|331|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-12|79|331|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-13|79|331|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-14|79|334|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-15|79|334|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|1|155|Rn-222 gas|2240|working level months|Inhalation|inhaled at 1200 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-16|79|334|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-1|79|241|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-2|79|256|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|benign,MPATH: 551 - sarcoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-3|79|283|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-4|79|294|Other deterministic changes|Lower respiratory system|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-5|79|317|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-6|79|323|Other deterministic changes|Lower respiratory system|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-7|79|328|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-8|79|328|Neoplasia malignant|Lower respiratory system|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-9|79|330|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-10|79|331|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-11|79|331|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-12|79|331|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-13|79|331|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-14|79|334|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-15|79|334|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-4-79|Rn-BP25+155d-WL 2240,33 4/79|2|310|benzopyrene|25|milligrams per kg animal|Injection, intraperitoneal|12 IP inject. 7 d interval|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-4-79-16|79|334|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
